Advice You
#1 in Business Subscribe Email Print

You are here: Home > Business > Management > Knowing The Type Of Viruses That Are Plaguing The Company Is Half The Cure

Tags

  • other
  • external
  • biological products
  • biological products

  • Links

  • 13 Extra Costs to be Aware of Before Buying a Home
  • Designing Your Log Home: Tips To Keep You Out of Trouble
  • Nokia N73 - Click Print-Quality Photographs
  • Advice You - Knowing The Type Of Viruses That Are Plaguing The Company Is Half The Cure

    Just as a competent medical practitioner needs to understand the causes of a disease, a competent turnaround manager must understand the causes of the company
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    ’s decline.

    Much like human beings, companies are perpetually faced with all kinds of viruses or threats to their health, some are internally created whilst
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    thers are externally generated. The human body is always battling all these threats so as to maintain the equilibrium of health or homeostasis. Likewise, an
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    organisation that is able to successfully address both internal and external problems (from operational hiccups to market threats) will bound to enjoy corp
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    rate health and longevity.

    The troubled company usually gets attacked by two types of problems – internal and external viruses.

    Many of the internal viruses
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    are generated by the company and are actually within the company’s control. They are usually associated with weak management and poor financial system. The
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    onslaught of such viral attacks can lead to bad or untimely business decisions, poor financial control and other related problems. The medical analogy for e
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    liminating internal viruses may merit the use of surgery such as downsizing, restructuring or change.

    For example a poll of the members of the Turnaround Man
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    gement Association, people whose job is to rescue troubled businesses revealed that while 22 percent of turnaround professionals cited increased competition
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    as a reason for business failures, a full 58 percent squarely put the blame on faulty management decision-making. Similarly, other studies have found that
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    nternal, rather than external causes are behind up to 90 percent of company failures. Peter Tourtellot, former chairman and now a turnaround manager himself
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    noted that one of the most common mistakes was that troubled companies did not listen to their customers. He also found that communication was sadly lacking i
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    n most of the troubled businesses.

    Business journalist, Bruce G. Posner cited some of management’s most embarrassing mistake. “What kills companies,” he sa
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    d, “has less to do with insufficient money, talent, or information than with something more basic: a shortage of good judgment and understanding at the very
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    top.”

    External viruses being macro in nature are often beyond the company’s control. The entire industry or marketplace or even the whole country may be str
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    cken by the same type of external viruses. The attacks can be silent, swift and often appear non-threatening at the beginning. Examples of external viruses
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    include economic recession, change in technology and consumer behaviour, political turmoil, natural disasters and terrorist attacks.

    Such external viruses
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    re harder to eliminate and predict. Sometimes, even having a strong management team is inadequate to cope with external viruses as the corporate culture is
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    unable to manage change expediently. The remedy is to foster a strong and healthy corporate culture that is the immune system of the company.

    Thus the best p
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    ognosis is to identify the viruses, predict their potential damage and eradicate them before they are able to penetrate, attack and wreak havoc to your system


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.adviceyou.org.ua/article/21959/adviceyou-Knowing-The-Type-Of-Viruses-That-Are-Plaguing-The-Company-Is-Half-The-Cure.html">Knowing The Type Of Viruses That Are Plaguing The Company Is Half The Cure</a>

    BB link (for phorums):
    [url=http://www.adviceyou.org.ua/article/21959/adviceyou-Knowing-The-Type-Of-Viruses-That-Are-Plaguing-The-Company-Is-Half-The-Cure.html]Knowing The Type Of Viruses That Are Plaguing The Company Is Half The Cure[/url]

    Related Articles:

    Accounting Business Outsource Process is a Good Approach

    Air Traffic Controller Employment Crisis Looming

    How to Pay a Powerful Compliment

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com

    wymiana linkow sprawdz autoryzacje nieautoryzowano brak autoryzacji 905